Washington Cannabis Sales Slide as Glut and Taxes Squeeze Market

Washington’s legal cannabis retailers rang up about $1.14 billion in sales in 2025, according to newly updated state tax data — a modest step down from the prior year, but roughly a fifth below the market’s 2021 peak. For one of the country’s oldest adult-use markets, the figure confirms what operators have felt for three years running: growth has stopped, and the contraction looks structural rather than cyclical.

Inside the numbers

The one-year move is small. Retail sales slipped from about $1.18 billion in 2024 to $1.14 billion in 2025, a decline of roughly 3%, per the Washington State Department of Revenue. The longer arc is the real story. Retail sales have declined every year since 2021, when the market last set a record — a steady erosion that dwarfs any single year’s move.

Tax receipts have dropped faster than sales. Washington’s cannabis excise collections came to roughly $438 million in the fiscal year that ended June 30, 2025, down from a record above $555 million in fiscal 2021, state figures show. Part of that gap is deliberate: since 2024, registered medical patients have been exempt from the state’s 37% excise tax, pulling some revenue off the top. But most of it tracks a simpler dynamic — as wholesale and retail prices fall, a percentage-based tax collects less on every gram sold, even as cannabis has grown into a multibillion-dollar revenue source for states nationally.

What’s dragging the market down

The clearest culprit is oversupply. Licensed production roughly tripled between 2017 and 2023 — to more than 360,000 pounds — even as sales only doubled, according to an analysis commissioned for the state’s 2025 market study. The imbalance has landed hardest on the supply side of the business. The number of licensed cannabis producers has fallen 31.6% since 2017, while the retail count held roughly steady, the July 2025 audit by the state’s Joint Legislative Audit and Review Committee found. Producers also churn faster than retailers, carrying a higher failure rate and annual turnover. Washington is not alone: adult-use revenue has begun slipping across other mature markets as prices fall.

Taxes compound the pressure. Washington’s 37% excise is the steepest state cannabis tax in the country, and it stacks on top of the federal tax penalty that bars state-legal operators from deducting ordinary business expenses. Combined, some analyses put effective tax rates as high as 70% for certain operators — a load that leaves little room for margin in a market where prices are already falling, and one that keeps high taxes squarely in the debate over why legal sales are eroding.

Then there is the competition operators cannot tax away. Analysis commissioned for the state estimated that licensed retailers captured only about 60% to 70% of Washington’s total cannabis sales in 2023; industry groups put the legal share closer to half. Either way, a large slice of demand still flows to untaxed, unlicensed sellers — a gap widened by local retail bans in parts of the state that push consumers toward the illicit market rather than a licensed store.

Why rescheduling won’t rescue Washington

Operators watching these numbers had pinned some hope on federal rescheduling. The move to reclassify cannabis to Schedule III would, in theory, lift the federal tax penalty that inflates their effective rates. But it likely won’t reach most Washington licensees. Because the state runs a single recreational market with no separate medical license tier, its businesses sit outside the medical framework the reclassification targets, leaving them subject to the same federal disallowance as before.

The state is managing the downturn with limited visibility into its own market. Washington remains one of the few adult-use states without a working seed-to-sale traceability system; the audit found that total sales in the regulator’s reporting system did not reconcile with the tax data collected separately, and the agency does not expect a replacement until 2031. For a market this far into contraction, that is a meaningful blind spot for regulators and for the operators trying to plan around them.

For now, the door to new competition stays mostly shut. The Liquor and Cannabis Board is not accepting new producer, processor, or retailer applications outside its social equity program — a freeze that limits fresh entrants but does nothing to relieve the operators already fighting oversupply, high taxes, and a persistent illicit market. Washington’s experiment is not failing so much as maturing into a harder, lower-margin business, and its 2025 numbers show how much of that pressure is built into the market’s design.